N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide

C46H56F2N10O8 — CID 160610344

IUPACN-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide
SMILESCN(CCCOCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1CCC(n2cc(NC(=O)c3coc(-c4ccnc(N[C@H]5CCCC[C@H]5O)c4)n3)c(C(F)F)n2)CC1
InChIInChI=1S/C46H56F2N10O8/c1-56(20-6-22-65-21-5-18-49-32-9-4-7-30-39(32)46(64)58(45(30)63)35-15-16-38(60)54-43(35)62)24-27-11-13-29(14-12-27)57-25-33(40(55-57)41(47)48)52-42(61)34-26-66-44(53-34)28-17-19-50-37(23-28)51-31-8-2-3-10-36(31)59/h4,7,9,17,19,23,25-27,29,31,35-36,41,49,59H,2-3,5-6,8,10-16,18,20-22,24H2,1H3,(H,50,51)(H,52,61)(H,54,60,62)/t27?,29?,31-,35?,36+/m0/s1
InChIKeyXQSWZEBBKYNRAB-LUPNAWFCSA-N
MW915.01 g/mol
LogP5.81
Rot. Bonds19

About N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide

N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide (PubChem CID 160610344) has the molecular formula C46H56F2N10O8 and a molecular weight of 915.01 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide.

Molecular Properties

Compound NameN-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide
PubChem CID160610344
Molecular FormulaC46H56F2N10O8
Molecular Weight915.01 g/mol
Exact Mass914.43
IUPAC NameN-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide
SMILESCN(CCCOCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1CCC(n2cc(NC(=O)c3coc(-c4ccnc(N[C@H]5CCCC[C@H]5O)c4)n3)c(C(F)F)n2)CC1
InChIInChI=1S/C46H56F2N10O8/c1-56(20-6-22-65-21-5-18-49-32-9-4-7-30-39(32)46(64)58(45(30)63)35-15-16-38(60)54-43(35)62)24-27-11-13-29(14-12-27)57-25-33(40(55-57)41(47)48)52-42(61)34-26-66-44(53-34)28-17-19-50-37(23-28)51-31-8-2-3-10-36(31)59/h4,7,9,17,19,23,25-27,29,31,35-36,41,49,59H,2-3,5-6,8,10-16,18,20-22,24H2,1H3,(H,50,51)(H,52,61)(H,54,60,62)/t27?,29?,31-,35?,36+/m0/s1
InChIKeyXQSWZEBBKYNRAB-LUPNAWFCSA-N
XLogP5.81
TPSA226.15 Ų
H-Bond Donors5
H-Bond Acceptors15
Rotatable Bonds19
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500915.01
LogP ≤ 55.81
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide (CID 160610344) is N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide is CN(CCCOCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O)CC1CCC(n2cc(NC(=O)c3coc(-c4ccnc(N[C@H]5CCCC[C@H]5O)c4)n3)c(C(F)F)n2)CC1.
What is the InChIKey of N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide?
The InChIKey is XQSWZEBBKYNRAB-LUPNAWFCSA-N. The full InChI is InChI=1S/C46H56F2N10O8/c1-56(20-6-22-65-21-5-18-49-32-9-4-7-30-39(32)46(64)58(45(30)63)35-15-16-38(60)54-43(35)62)24-27-11-13-29(14-12-27)57-25-33(40(55-57)41(47)48)52-42(61)34-26-66-44(53-34)28-17-19-50-37(23-28)51-31-8-2-3-10-36(31)59/h4,7,9,17,19,23,25-27,29,31,35-36,41,49,59H,2-3,5-6,8,10-16,18,20-22,24H2,1H3,(H,50,51)(H,52,61)(H,54,60,62)/t27?,29?,31-,35?,36+/m0/s1.
What are the key properties of N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide?
N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide has a molecular weight of 915.01 g/mol, XLogP of 5.81, 19 rotatable bonds, 5 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-1-[4-[[3-[3-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]propoxy]propyl-methylamino]methyl]cyclohexyl]pyrazol-4-yl]-2-[2-[[(1S,2R)-2-hydroxycyclohexyl]amino]-4-pyridinyl]-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 160610344), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).